---
title: Explicyte vs GeNext Genomics Pvt. Ltd.
slug_a: explicyte
slug_b: genextgenomics
site: cro
review_signal_gate: closed
canonical_path: /compare/explicyte/genextgenomics
---

# Explicyte vs GeNext Genomics Pvt. Ltd.

Side-by-side profile data from each company listing on this directory.

## Explicyte

- Profile: [/companies/explicyte](/companies/explicyte)

Explicyte — Oncology CRO offering FFPE target discovery, 2D/3D immuno-oncology efficacy and mechanism-of-action assays, and ISO-certified IHC/IF trial biomarker services. Serves biotech and pharma sponsors.

Services: 13. Modalities: 2. Indications: 1. Locations: 1. Certifications: 3. The strongest documented coverage currently appears in services (13).

### Services

- Discovery Research
- Target Identification & Validation
- Preclinical In Vitro Studies
- In Vitro Pharmacology
- Biomarker Assays
- Flow Cytometry Services
- Translational Research
- Immunology & Inflammation Services
- Oncology Specialty Services
- Pathology & Histology Services
- Genomics & Sequencing Services
- Proteomics Services
- Bioinformatics & Data Science

### Modalities

- Biologics (Other)
- Antibody-Drug Conjugate (ADC)

### Indications

- Oncology

### Phases

- Discovery
- Preclinical (General)
- Preclinical (IND-Enabling)

### Sourcing models

- Data not yet provided.

## GeNext Genomics Pvt. Ltd.

- Profile: [/companies/genextgenomics](/companies/genextgenomics)

GeNext Genomics Pvt. Ltd. — GeNext Genomics is a central India-based contract research organization offering recombinant protein, antibody, and assay development services. The company also sells research reagents and diagnostic kits.

Services: 8. Modalities: 2. Indications: 0. Locations: 1. Certifications: 0. The strongest documented coverage currently appears in services (8).

### Services

- Discovery Research
- Protein Engineering
- Immunology & Inflammation Services
- Proteomics Services
- Bioinformatics & Data Science
- Monoclonal Antibody (mAb) Manufacturing
- Recombinant Protein Manufacturing
- Cell-Line Development

### Modalities

- Biologics (Monoclonal Antibodies)
- Biologics (Other)

### Indications

- Data not yet provided.

### Phases

- Discovery

### Sourcing models

- Data not yet provided.